Regeneron Pharmaceuticals Aktie

Kaufen
Verkaufen
703,60 EUR -3,80 EUR -0,54 %
739,44 USD +1,44 USD +0,20 %
nachbörslich
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 77,36 Mrd. EUR

KGV 25,26 Div. Rendite 0,00%

WKN 881535

ISIN US75886F1075

Symbol REGN


Regeneron Pharmaceuticals Aktie Analyse

06.10.11 Regeneron Pharmaceuticals outperform RBC Capital Markets
22.09.11 Regeneron Pharmaceuticals outperform RBC Capital Markets
23.08.11 Regeneron Pharmaceuticals buy Citigroup Corp.
18.08.11 Regeneron Pharmaceuticals outperform RBC Capital Markets
12.08.11 Regeneron Pharmaceuticals buy Citigroup Corp.
28.07.11 Regeneron Pharmaceuticals outperform RBC Capital Markets
16.06.11 Regeneron Pharmaceuticals buy Citigroup Corp.
09.05.11 Regeneron Pharmaceuticals buy Needham & Company, LLC
03.05.11 Regeneron Pharmaceuticals overweight Barclays Capital
02.05.11 Regeneron Pharmaceuticals overweight Barclays Capital
20.04.11 Regeneron Pharmaceuticals overweight Barclays Capital
14.04.11 Regeneron Pharmaceuticals overweight Barclays Capital
17.03.11 Regeneron Pharmaceuticals overweight Barclays Capital
14.03.11 Regeneron Pharmaceuticals overweight Barclays Capital
02.03.11 Regeneron Pharmaceuticals overweight Barclays Capital
25.02.11 Regeneron Pharmaceuticals outperform RBC Capital Markets
15.02.11 Regeneron Pharmaceuticals overweight Barclays Capital
03.08.10 Regeneron Pharmaceuticals buy Needham & Company, LLC
19.07.10 Regeneron Pharmaceuticals buy Needham & Company, LLC
12.11.09 Regeneron Pharmaceuticals buy Merriman Curhan Ford & Co
06.08.09 Regeneron Pharmaceuticals outperform Credit Suisse Group
05.08.09 Regeneron Pharmaceuticals buy Merriman Curhan Ford & Co
30.03.09 Regeneron Pharmaceuticals buy Piper Jaffray & Co.
27.02.09 Regeneron Pharmaceuticals outperform RBC Capital Markets
24.10.08 Regeneron Pharmaceuticals buy Merriman Curhan Ford & Co
04.12.07 Regeneron Pharmaceuticals above average Caris & Company, Inc.
03.12.07 Regeneron Pharmaceuticals outperform Credit Suisse Group
25.06.07 Regeneron Pharmaceuticals Global Biotech Investing
15.12.06 Regeneron Pharmaceuticals outperform RBC Capital Markets
09.11.06 Regeneron Pharmaceuticals buy Needham & Co
19.10.06 Regeneron Pharmaceuticals overweight Lehman Brothers
19.10.06 Regeneron Pharmaceuticals outperform RBC Capital Markets
27.07.06 Regeneron Pharmaceuticals outperform RBC Capital Markets
27.12.05 Regeneron Pharmaceuticals overweight Lehman Brothers
27.12.05 Regeneron Pharmaceuticals Overweight Lehman Brothers
24.10.05 Regeneron Pharmaceuticals Overweight Morgan Stanley